C T Jordan
Overview
Explore the profile of C T Jordan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
1510
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ammar M, Jordan C, Cao L, Lim E, Bouchlaka Souissi C, Jrad A, et al.
Br J Dermatol
. 2015 Sep;
174(2):330-7.
PMID: 26358359
Background: Rare highly penetrant gain-of-function mutations in caspase recruitment domain family, member 14 (CARD14) can lead to psoriasis, a chronic inflammatory disease of the skin and other organs. Objectives: To...
2.
Callahan K, Minhajuddin M, Corbett C, Lagadinou E, Rossi R, Grose V, et al.
Leukemia
. 2014 Mar;
28(10):1960-8.
PMID: 24577530
Identification of agents that target human leukemia stem cells is an important consideration for the development of new therapies. The present study demonstrates that rocaglamide and silvestrol, closely related natural...
3.
Ammar M, Bouchlaka-Souissi C, Helms C, Zaraa I, Jordan C, Anbunathan H, et al.
Br J Dermatol
. 2012 Sep;
168(3):583-7.
PMID: 23013406
Background: Psoriasis is a relapsing chronic inflammatory skin disease affecting all population groups, with a peak prevalence of 3% in northern European and Scandinavian caucasians. Epidemiological studies have implicated a...
4.
Sampson E, McMurray H, Hassane D, Newman L, Salzman P, Jordan C, et al.
Oncogene
. 2012 Sep;
32(33):3809-18.
PMID: 22964631
Malignant cell transformation commonly results in the deregulation of thousands of cellular genes, an observation that suggests a complex biological process and an inherently challenging scenario for the development of...
5.
Korver W, Zhao X, Singh S, Pardoux C, Zhao J, Guzman M, et al.
Leukemia
. 2009 May;
23(9):1587-97.
PMID: 19440216
IREM-1 is an inhibitory cell surface receptor with an unknown function and is expressed on myeloid cell lineages, including cell lines derived from acute myeloid leukemia (AML) patients. We have...
6.
Mendler J, Kelly J, Voci S, Marquis D, Rich L, Rossi R, et al.
Ann Oncol
. 2008 May;
19(10):1759-64.
PMID: 18504251
Background: Given the significant activity and tolerability of gemcitabine in patients with relapsed Hodgkin's lymphoma (HL), the critical role that nuclear factor kappa B (NF-kappaB) appears to play in the...
7.
The use of adenoviral vectors for genetic manipulation and analysis of primitive hematopoietic cells
Jordan C, Vanin E, Marini F
Curr Gene Ther
. 2002 Jul;
1(3):257-65.
PMID: 12109141
Gene transfer into stem cells has long been studied as a means by which primitive hematopoietic cells could be characterized and manipulated. While a variety of strategies have been attempted,...
8.
Jordan C
Leukemia
. 2002 Apr;
16(4):559-62.
PMID: 11960332
It is well known in the field of acute myelogenous leukemia (AML) that many different translocations and genetic aberrancies are found with the various forms of the disease. Indeed, specific...
9.
10.
Guzman M, Neering S, Upchurch D, Grimes B, Howard D, Rizzieri D, et al.
Blood
. 2001 Oct;
98(8):2301-7.
PMID: 11588023
Human acute myelogenous leukemia (AML) is thought to arise from a rare population of malignant stem cells. Cells of this nature, herein referred to as leukemic stem cells (LSCs), have...